[1]
2026. Clinical Outcomes of Next-Generation Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia. Annals of Medicine and Medical Sciences. (Feb. 2026), 69–76. DOI:https://doi.org/10.5281/.